Skip to main content

Zaki

Analyst

Jefferies

Equibles does not estimate personal net worth.

About Zaki

Zaki is recorded as Analyst at Jefferies. Zaki has spoken on 2 earnings calls across 2 companies, most recently for Cytokinetics Inc on November 5, 2025. Those appearances were for Cytokinetics Inc (CYTK) and Biomarin Pharmaceutical Inc (BMRN). The companies whose calls Zaki spoke on are classified in the Healthcare sector.

Zaki on recent calls

“So just again on non-obstructive, you've talked about how Bristol's Odyssey study had an outlier placebo, and to us, it almost seems like their standard deviation on KCCQ in particular, came in higher than they expected in their protocol.”
Analyst — Jefferies, Cytokinetics Inc Q3 FY2025 Earnings Call ·
“Just on the DMD corrector 351, when we looked at the recently published mouse data, it looks like there's some mild liver signals in those mouse models at the higher exposures and some inflammation in the liver and muscle in those mice.”
Analyst — Jefferies, Biomarin Pharmaceutical Inc Q1 FY2025 Earnings Call ·

Affiliation history

  • Jefferies

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity